Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia
- PMID: 35461601
- DOI: 10.1016/j.kint.2021.12.033
Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia
Comment in
-
The authors reply.Kidney Int. 2022 May;101(5):1086-1087. doi: 10.1016/j.kint.2022.02.005. Kidney Int. 2022. PMID: 35461602 No abstract available.
Comment on
-
Management of acute kidney injury in symptomatic multiple myeloma.Kidney Int. 2021 Mar;99(3):570-580. doi: 10.1016/j.kint.2020.11.010. Epub 2021 Jan 10. Kidney Int. 2021. PMID: 33440212 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
